Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 References  














Morbilliform






العربية
Français
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


Morbilliform
SpecialtyDermatology

The term morbilliform refers to a rash that looks like measles.[1][2] The rash consists of macular lesions that are red and usually 2–10 mm in diameter but may be confluent in places.[3] A morbilliform rash is a rose-red flat (macular) or slightly elevated (maculopapular) eruption, showing circular or elliptical lesions varying in diameter from 1 to 3 mm, with healthy-looking skin intervening.[citation needed]

Patients with measles will have the rash but there are other syndromes and infections that will display the same symptom such as patients with Kawasaki disease,[4] meningococcal petechiaeorWaterhouse-Friderichsen syndrome,[4] Dengue, Roseola, congenital syphilis,[5] rubella,[4] Echovirus 9,[4] drug hypersensitivity reactions (in particular with certain classes of antiretroviral drugs, such as abacavir and nevirapine, and also the antiepileptic drug phenytoin), or other conditions may also have a morbilliform rash. It has also been mentioned as a possible manifestation of onset or recovery from COVID-19.[6]

One cause of morbilliform rash is an allergic reaction to transfused blood/blood components. In such a case, the skin lesions would develop within a few hours (Approx. 4hours) of transfusion along with pruritus. The condition may even present with other symptoms, such as conjunctival oedema, oedema in the lips and tongue, and even localised angioedema. On rare occasions, the condition may even escalate to anaphylactic shock where pulmonary restrictions are seen. The associated cause for this is a reaction against an allergen that is seldom identified during testing. Transfusing products with anti-IgA antibodies to IgA-deficient patients has also been a suspected cause for such reactions. Management usually relates to the stoppage of transfusion for around 30minutes, until given antihistamines take effect. Transfusion may even be continued after, if no further progression is seen.

References[edit]

  1. ^ Haber, Jessica S.; Cipriano, Sarah D.; Oza, Vikash S. (April 2022). "Morbilliform Eruptions in the Hospitalized Child". Dermatologic Clinics. 40 (2): 191–202. doi:10.1016/j.det.2021.12.006. ISSN 0733-8635. PMC 8896762. PMID 35366972.
  • ^ Morris-Jones, Rachel (2019). "10. The skin and systemic disease". In Morris-Jones, Rachael (ed.). ABC of Dermatology (7th ed.). Hoboken: Wiley Blackwell. pp. 75–77. ISBN 978-1-119-48899-6.
  • ^ Primary Care Dermatology Module. Nomenclature of Skin Lesions The University of Wisconsin. Department of Pediatrics. Retrieved on Nov 30, 2009
  • ^ a b c d thefreedictionary.com > morbilliform rash Retrieved on Nov 30, 2009
  • ^ American Family Physician Sept 1st 2012 Vol 86 No 5 pp381-482 Syphilis: A re-emerging infection.
  • ^ "COVID-19 | DermNet NZ".

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=Morbilliform&oldid=1219941752"

    Categories: 
    Dermatologic terminology
    Pediatrics
    Measles
    Hidden categories: 
    Articles with short description
    Short description is different from Wikidata
    All articles with unsourced statements
    Articles with unsourced statements from August 2022
     



    This page was last edited on 20 April 2024, at 20:48 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki